PEVAX
Price
$15.05
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Net Assets
N/A
VSIIX
Price
$45.09
Change
-$0.04 (-0.09%)
Updated
May 22 closing price
Net Assets
51.69B
Interact to see
Advertisement

PEVAX vs VSIIX

Header iconPEVAX vs VSIIX Comparison
Open Charts PEVAX vs VSIIXBanner chart's image
PACE Small/Medium Co Value Equity A
Price$15.05
Change-$0.00 (-0.00%)
VolumeN/A
Net AssetsN/A
Vanguard Small Cap Value Index I
Price$45.09
Change-$0.04 (-0.09%)
VolumeN/A
Net Assets51.69B
PEVAX vs VSIIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEVAX vs. VSIIX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEVAX is a Buy and VSIIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSIIX pays higher dividends than PEVAX: VSIIX (2.35) vs PEVAX (0.77). PEVAX was incepted earlier than VSIIX: PEVAX (25 years) vs VSIIX (25 years). PEVAX (1.29) is less costly to investors than VSIIX (0.06). PEVAX is a more actively managed with annual turnover of: 119.00 vs. VSIIX (16.00). PEVAX has a lower initial minimum investment than VSIIX: PEVAX (1000) vs VSIIX (5000000). VSIIX annual gain was more profitable for investors over the last year : 2.56 vs. PEVAX (-17.58). VSIIX return over 5 years is better than : 95.60 vs. PEVAX (5.39).
PEVAXVSIIXPEVAX / VSIIX
Total Expense Ratio1.290.062,150%
Annual Report Gross Expense Ratio1.290.062,150%
Fund Existence25 years25 years-
Gain YTD-4.908-2.359208%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A51.7B-
Annual Yield % from dividends0.772.3533%
Returns for 1 year-17.582.56-686%
Returns for 3 years-21.7923.76-92%
Returns for 5 years5.3995.606%
Returns for 10 years-23.0383.58-28%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYLCX72.77N/A
N/A
Rydex Leisure C
LEGCX48.91N/A
N/A
Columbia Large Cap Growth C
MNBAX19.75N/A
N/A
Manning & Napier Pro-Blend Extnd Term S
PMVFX24.75N/A
N/A
PGIM Quant Solutions Mid-Cap Val R4
MVISX41.00N/A
N/A
Patient Opportunity IS